Emily Titus

Vice President, Process Sciences

Emily Titus picture

Emily Titus

Notch Therapeutics

Vice President, Process Sciences

Emily obtained her PhD from the Institute of Biomaterials and Biomedical Engineering at the University of Toronto, where she used a combination of laboratory and bioinformatics approaches to define and interpret gene regulatory networks controlling embryonic stem cell fate decisions. At Notch Therapeutics, she is responsible for building the start-up team and driving the execution of development programs. Previously, she held the position of Vice President, Technology Advancement at CCRM, where she built cell reprogramming, genome engineering and pluripotent stem cell differentiation programs and led the company incubation program that culminated in the launch of Notch Therapeutics.